Defects in auxiliary fuel oxidation and mitochondrial pyruvate transport mark transition to overt heart failure in Tgαq*44 mice
Olkowicz M, Jedrzejewska A, Tyrankiewicz U, Fedak FA, Berkowicz P, Kwiatkowski G, Rosales-Solano H, Roy KS, Karas A, Krol O, Tomczyk M, Smolenski RT, Pawliszyn J, Chlopicki S. Defects in auxiliary fuel oxidation and mitochondrial pyruvate transport mark transition to overt heart failure in Tgαq*44 mice. J Transl Med. 2026 Mar 3;24(1):485.
Mouse
Cardiovascular diseases
2026
Exercise mitigates IL-27-induced muscle atrophy following myocardial infarction through anti-inflammatory mechanisms
Li Y, Yin G, Li S, Zheng Q, Jiang Y, Li C, Yang L, Li H, Chen X, Yang P, Sun L. Exercise mitigates IL-27-induced muscle atrophy following myocardial infarction through anti-inflammatory mechanisms. J Transl Med. 2026 Jan 24;24(1):271.
Rat
Cardiovascular diseases
2026
NAT10-Mediated ac4C-Modification Exacerbates Ferroptosis by Stabilizing HMOX1 in Deep Vein Thrombosis
Zhang Y, Zhang Z, Liu X, Chu C, Yu X, Han Q, Li W, Zhang T, Zu H, Fan N, Wei R, Shi F, Li F, Xu F, Wang B, Li X. NAT10-Mediated ac4C-Modification Exacerbates Ferroptosis by Stabilizing HMOX1 in Deep Vein Thrombosis. Arterioscler Thromb Vasc Biol. 2026 Feb;46(2):e323986.
Mouse
BV
2025
Tetrahedral DNA Nanostructures as a Multifactorial Nanotherapeutic Platform for Deep Vein Thrombosis: Targeting Necroptosis, Oxidative Stress, and Inflammation
Li Y, Cao W, Lv Y, Yang H, Xu L, Lu Y. Tetrahedral DNA Nanostructures as a Multifactorial Nanotherapeutic Platform for Deep Vein Thrombosis: Targeting Necroptosis, Oxidative Stress, and Inflammation. Int J Nanomedicine. 2025 Nov 18;20:13837-13855.
Mouse
BV
2025
Theogallin Protects Myocardial Ischemia-Reperfusion Injury by Inhibiting the Interleukin-17 Signaling Pathway
Zhu F, Cheng H, Luo Z, Cao A, Yu T, Ge H, Hu S, Xie Z, Li D. Theogallin Protects Myocardial Ischemia-Reperfusion Injury by Inhibiting the Interleukin-17 Signaling Pathway. J Agric Food Chem. 2025 Aug 6;73(31):19373-19385.
Rat
Cardiovascular diseases
2025
Optimization of siRNA therapeutics targeting MIAT for cardioprotection in myocardial ischemia/reperfusion injury
Ma XR, Yan TM, Pan Y, Jiang ZH. Optimization of siRNA therapeutics targeting MIAT for cardioprotection in myocardial ischemia/reperfusion injury. Mol Ther Nucleic Acids. 2025 Oct 18;36(4):102747.
Rat
Cardiovascular diseases
2025